Neurogene Market Cap

Neurogene has a market cap or net worth of $385.08 million as of April 26, 2024. Its market cap has increased by 929.61% in one year.

Market Cap

385.08M

Enterprise Value

203.67M

1-Year Change

929.61%

Ranking

#3153

Market Cap Chart

Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $385.08M, an increase of 237.49%. That is a compound annual growth rate of 12.74%.

Market Cap History

Date	Market Cap	% Change
Apr 26, 2024	385.10M	0.31%
Apr 25, 2024	383.90M	-1.18%
Apr 24, 2024	388.50M	-3.02%
Apr 23, 2024	400.60M	1.83%
Apr 22, 2024	393.40M	0.38%
Apr 19, 2024	391.90M	-3.45%
Apr 18, 2024	405.90M	-6.13%
Apr 17, 2024	432.40M	-4.42%
Apr 16, 2024	452.40M	-5.97%
Apr 15, 2024	481.10M	-5.72%
Apr 12, 2024	510.30M	3.57%
Apr 11, 2024	492.70M	-1.02%
Apr 10, 2024	497.80M	-5.45%
Apr 9, 2024	526.50M	-1.57%
Apr 8, 2024	534.90M	0.73%
Apr 5, 2024	531.00M	-3.12%
Apr 4, 2024	548.10M	-2.96%
Apr 3, 2024	564.80M	-1.45%
Apr 2, 2024	573.10M	-4.69%
Apr 1, 2024	601.30M	-8.09%
Mar 28, 2024	654.20M	3.33%
Mar 27, 2024	633.10M	-0.39%
Mar 26, 2024	635.60M	0.86%
Mar 25, 2024	630.20M	-1.70%
Mar 22, 2024	641.10M	1.34%

View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lexicon Pharmaceuticals	393.98M
Organogenesis Holdings	393.25M
MaxCyte	389.44M
Mereo BioPharma Group	389.36M
Replimune Group	388.58M
NeuroPace	384.35M
PepGen	383.17M
Alto Neuroscience	381.75M

Market Cap Rankings